Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · with National Institute of Neurological Disorders and Stroke (NINDS) · NCT07278388
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- July 16, 2025
- Record last updated
- December 12, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.
Being studied: Physical Fatigue
Conditions: PASC Post Acute Sequelae of COVID 19; Fatigue
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 to 75 years old.
- Have received a clinical diagnosis of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID syndrome using the criteria specified by Thaweethai, et al., 2023 (JAMA). This symptom checklist provides a score based on the number and severity of symptoms. An individual with a score >12 is classified as having PASC.
- Currently experiencing Fatigue/Brain Fog as assessed with the Post-COVID symptom checklist and the PedsQL questionnaire.
Exclusion Criteria
- Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
- Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
- Congestive heart failure.
- Peripheral artery disease with claudication.
- Cancer.
- Pulmonary or renal failure.
- Unstable angina.
- Uncontrolled hypertension (more than 190/110 mmHg).
- Severe aphasia.
- Orthopedic or pain conditions.
- Have had exposure to metal or metal implants, due to the hazardous effects of the magnetic field.
- If on immunomodulatory therapy, they must have been on that therapy for at least 6 months before the start of the study.
Healthy age- and sex-matched controls for PASC - Exclusion criteria: Participants with a history of any of the following will be excluded from the study:
- Hospitalization due to SARS-CoV-2 infection.
- Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
- Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
- Congestive heart failure.
- Peripheral artery disease with claudication.
Recruiting US locations
Kennedy Krieger Institute
Baltimore, MD 21201
Site contact: Anthony Gonzalez · 443-923-2716 · gonzalezan@kennedykrieger.org
Study contacts (from the official record)
- Anthony Gonzalez · 443-923-2716 · gonzalezan@kennedykrieger.org
- Vikram Chib, PhD
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55